| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sns-314 | aurora kinase a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.21 | investigational,phase 1 | inhibitor |
| sns-314 | aurora kinase a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.21 | investigational,phase 1 | unknown |
| sns-314 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.15 | phase 1 | inhibitor |
| sns-314 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.15 | phase 1 | unknown |
| sns-314 | aurora kinase c | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.69 | investigational,phase 1 | inhibitor |
| sns-314 | aurora kinase c | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.69 | investigational,phase 1 | unknown |
| click here to return to the previous page | ||||||||